FDA Memo Reveals Link Between COVID-19 Vaccines and Child Deaths

An internal memo from the Food and Drug Administration (FDA) has disclosed that agency scientists have identified a concerning link between COVID-19 vaccinations and child fatalities. According to the memo obtained by The Epoch Times, at least ten child deaths are under scrutiny for their potential connection to the vaccination process. This marks a significant acknowledgment from the FDA regarding the serious implications of the vaccine on younger populations.

The memo, authored by Dr. Vinay Prasad, the director of the FDA’s Center for Biologics Evaluation and Research (CBER), details findings from a comprehensive review conducted by the Office of Biostatistics and Pharmacovigilance. This review analyzed 96 death reports voluntarily submitted to the Vaccine Adverse Event Reporting System (VAERS) from 2021 to 2024. The review concluded that at least ten of these reports met the criteria for a likely, probable, or possible causal link to COVID-19 vaccination.

Details of the Findings

The findings raise critical questions about vaccine safety, particularly regarding its administration in children. The review indicates that the FDA’s internal scientists have been closely monitoring adverse events following vaccinations. The identification of these fatalities as potentially vaccine-related represents a pivotal moment in the ongoing dialogue surrounding vaccine safety and efficacy.

According to the memo, the evaluation of the death reports was thorough, and the conclusion reached by the scientists reflects a careful consideration of the data. The acknowledgment that some deaths may be linked to vaccinations has stirred discussions within public health circles and among parents contemplating vaccination for their children.

Impact on Public Perception and Policy

This revelation may influence public perception of COVID-19 vaccinations, particularly among parents of young children. Health officials have consistently advocated for vaccination as a key tool in combating the pandemic. However, as more information about potential risks emerges, it may affect vaccination rates and public trust in health authorities.

The implications of this internal memo extend beyond public sentiment; they may also impact policy decisions regarding vaccination programs for children. The FDA’s commitment to transparency in reporting and analyzing adverse events is crucial as health agencies navigate the complexities of vaccine safety.

As the situation develops, it is essential for health officials to communicate clearly with the public about the findings and the steps being taken to ensure the safety of vaccines. The health community awaits further insights and recommendations from the FDA, especially regarding the ongoing monitoring of vaccine-related adverse events.

This internal memo serves as a reminder of the importance of vigilance in vaccine safety and the necessity for ongoing research and evaluation to protect public health, particularly for vulnerable populations such as children.